WhaleCreep

Engaged Capital LLC 13F holdings, Q1 2016

Hedge fundSEC filingsCompare with another fundHoldings as of 2016-03-31, filed 2016-05-16

Engaged Capital LLC disclosed 12 US equity positions worth $296.3m in its Q1 2016 13F filing. Its largest position is OUTERWALL INC at 30.4% of the reported book, followed by BHE and ROVIEUR. Versus Q4 2015 it opened 2 new positions, added to 7, reduced 0 and exited 1.

$296m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
12
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
30.4%
Largest position
The largest single position as a share of the reported equity book.
97.8%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
6
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
51
Quarters on file since Q4 2013
Quarters for which this manager's 13F holdings are on record.

Holdings

Against Q4 2015: 2 new, 7 added, 0 reduced, 1 exited

12 rows
OUTERWALL INC no ticker–30.4%$89.9m2.43m+919%added
BHE BENCHMARK ELECTRS INCTechnology18.9%$56.0m2.43m+188%added
ROVIEUR ROVI CORP–15.6%$46.1m2.25m0.0%held
JAMBA INC no ticker–7.6%$22.6m1.83m0.0%held
MED MEDIFAST INCConsumer Cyclical7.5%$22.3m737,4650.0%held
MX MAGNACHIP SEMICONDUCTOR CORPTechnology7.1%$21.0m3.85m+12%added
TRS TRIMAS CORPConsumer Cyclical4.0%$11.9m679,067+7.3%added
HEARTWARE INTL INC no ticker–2.6%$7.6m240,750+4.7%added
IWM ISHARES TR–2.1%$6.3m56,789–new
BDSIUSD BIODELIVERY SCIENCES INTL IN–2.0%$6.1m1.88m–new
LBYYQ LIBBEY INC–1.7%$5.0m270,064+76%added
AMAG AMAG PHARMACEUTICALS INC–0.5%$1.5m65,916+7.3%added

Exited since Q4 2015

1 row
HAIN HAIN CELESTIAL GROUP INC2.2%$3.5m

Sector mix

  • Unclassified62.5%
  • Technology26.0%
  • Consumer Cyclical11.5%

Book over time

Every quarter on file (51)
QuarterPositionsEquity book
Q2 202610$327m
Q1 20268$303m
Q4 20259$392m
Q3 20259$408m
Q2 20257$358m
Q1 20259$392m
Q4 20248$486m
Q3 20249$617m
Q2 202412$584m
Q1 202411$617m
Q4 20239$683m
Q3 20237$549m
Q2 20238$691m
Q1 202310$703m
Q4 20229$591m
Q3 20229$506m
Q2 20227$651m
Q1 20228$988m
Q4 20219$812m
Q3 20219$1.4bn
Q2 20219$1.3bn
Q1 20219$1.4bn
Q4 20209$1.2bn
Q3 202010$967m
Q2 202010$928m
Q1 20208$763m
Q4 20198$963m
Q3 20198$789m
Q2 20199$822m
Q1 201912$712m
Q4 201815$539m
Q3 201816$713m
Q2 201816$795m
Q1 201815$737m
Q4 201715$788m
Q3 201721$813m
Q2 201717$674m
Q1 201716$394m
Q4 201614$307m
Q3 201614$275m
Q2 201612$284m
Q1 201612$296m
Q4 201511$161m
Q3 201512$174m
Q2 201515$174m
Q1 201516$134m
Q4 201413$123m
Q3 201413$135m
Q2 201412$144m
Q1 201415$146m
Q4 201312$142m

Where Engaged Capital LLC was early

20 rows
MED MEDIFAST INCQ1 20141 of 9212.0%17.3%22Exited by Q4 2020+465%
TRS TRIMAS CORPQ3 20141 of 836.7%16.5%12Exited by Q3 2017+7.5%
TEX TEREX CORP NEWQ4 20145 of 1261.2%2.4%2Exited by Q2 2015−4.6%
AWI ARMSTRONG WORLD INDS INC NEWQ4 201412 of 1331.2%1.3%2Exited by Q2 2015+12%
BG3 BIG 5 SPORTING GOODS CORPQ1 20152 of 642.4%2.4%2Exited by Q3 2015+7.1%
BHE BENCHMARK ELECTRS INCQ1 20152 of 714.2%24.1%17Exited by Q2 2019+9.2%
STKL SUNOPTA INCQ1 20152 of 922.6%16.5%30Exited by Q2 2023+117%
ABM ABM INDS INCQ2 20151 of 836.5%6.5%2Exited by Q4 2015−17%
MX MAGNACHIP SEMICONDUCTOR CORPQ2 20153 of 826.6%11.7%13Exited by Q4 2020+77%
ZIXI ZIX CORPQ2 20153 of 462.5%2.5%2Exited by Q4 2015−19%
HAIN HAIN CELESTIAL GROUP INCQ4 20158 of 1132.2%71.7%22Exited by Q2 2022−15%
UPBD UPBOUND GROUP INCQ4 20162 of 1118.4%20.2%31Exited by Q3 2024+173%
CLS CELESTICA INCQ3 20172 of 1680.5%2.5%5Exited by Q4 2018−13%
VYX NCR VOYIX CORPORATIONQ3 201718 of 1960.5%24.7%31Exited by Q2 2025−58%
APOG APOGEE ENTERPRISES INCQ4 20173 of 812.2%9.3%10Exited by Q2 2020−54%
ANIK ANIKA THERAPEUTICS INCQ2 20182 of 581.1%2.3%3Exited by Q1 2019+5.0%
UEIC UNIVERSAL ELECTRS INCQ2 20184 of 471.0%1.1%2Exited by Q4 2018+19%
GIL GILDAN ACTIVEWEAR INCQ4 20209 of 1273.6%4.4%4Exited by Q4 2021+30%
BRCC BRC INCQ1 20221 of 5133.9%33.9%18Held at last filing, Q2 2026−95%
NATL NCR ATLEOS CORPORATIONQ4 20231 of 888.9%15.4%6Exited by Q2 2025+8.6%

Concentration and tenure

27.4%
Median largest position, all quarters
The largest single position as a share of the reported equity book.
100%
Median top 10 weight, all quarters
The ten largest positions together, as a share of the reported equity book.
Concentrated
Style, by median largest position
3
Median completed holding, quarters